Psivant Therapeutics

Psivant Therapeutics is a biotechnology company based in Boston, Massachusetts. The company is privately held and employs 24 people. Psivant Therapeutics focuses on developing novel small molecule therapeutics. Their QUAISAR platform is designed to address biologically and genetically validated, but previously intractable, protein targets. The company differentiates itself through its physics-driven approach to drug design, which is tightly coupled to chemistry and biology research and development. This unique approach aims to overcome challenges in targeting previously inaccessible proteins. For more information about Psivant Therapeutics and their innovative drug development platform, please visit their website at psivant.com.